Back to Search
Start Over
Nivolumab-Induced Guillain-Barré Syndrome Coupled With Remarkable Disease Response in a Case of Heavily Pretreated Lung Adenocarcinoma.
- Source :
-
Clinical lung cancer [Clin Lung Cancer] 2020 Mar; Vol. 21 (2), pp. e65-e73. Date of Electronic Publication: 2019 Nov 21. - Publication Year :
- 2020
- Subjects :
- Adenocarcinoma of Lung pathology
Aged, 80 and over
Guillain-Barre Syndrome chemically induced
Guillain-Barre Syndrome immunology
Humans
Lung Neoplasms pathology
Male
Adenocarcinoma of Lung drug therapy
Antineoplastic Agents, Immunological adverse effects
Guillain-Barre Syndrome pathology
Lung Neoplasms drug therapy
Nivolumab adverse effects
Tumor Microenvironment immunology
Subjects
Details
- Language :
- English
- ISSN :
- 1938-0690
- Volume :
- 21
- Issue :
- 2
- Database :
- MEDLINE
- Journal :
- Clinical lung cancer
- Publication Type :
- Academic Journal
- Accession number :
- 31837925
- Full Text :
- https://doi.org/10.1016/j.cllc.2019.11.001